Richard S. Lindahl - Oct 15, 2025 Form 4 Insider Report for Emergent BioSolutions Inc. (EBS)

Role
EVP, Chief Financial Officer
Signature
/s/ Jessica Perl, Attorney-in-fact
Stock symbol
EBS
Transactions as of
Oct 15, 2025
Transactions value $
-$47,952
Form type
4
Date filed
10/17/2025, 04:02 PM
Previous filing
Jun 10, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
LINDAHL RICHARD S EVP, Chief Financial Officer 300 PROFESSIONAL DRIVE, GAITHERSBURG /s/ Jessica Perl, Attorney-in-fact 2025-10-17 0001196632

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EBS Common Stock Tax liability -$48K -5K -1.68% $9.60 291K Oct 15, 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of common stock withheld to pay taxes associated with vesting and settlement of restricted stock units.